Related Experiment Videos
Prevalence and Predictors of Bone and Ocular Complications in Children With Steroid-Sensitive Nephrotic Syndrome: A
Kajal Patel1, Mritunjay Kumar1, Swarastra P Singh2
1Paediatrics, All India Institute of Medical Sciences, Raebareli, Raebareli, IND.
Insights
Prolonged corticosteroid therapy in children with steroid-sensitive nephrotic syndrome (SSNS) can lead to reduced bone mineral density (BMD) and vision problems. Regular monitoring of bone health and eye exams is crucial for these children.
Area of Science:
- Pediatric Nephrology
- Endocrinology
- Ophthalmology
Background:
- Steroid-sensitive nephrotic syndrome (SSNS) often requires prolonged corticosteroid treatment.
- Long-term corticosteroid use may pose risks to bone mineral density (BMD) and ocular health in children.
Purpose of the Study:
- To assess BMD and ocular complications in children with SSNS undergoing long-term corticosteroid therapy.
- To identify factors linked to these complications, particularly steroid exposure.
Main Methods:
- Cross-sectional observational study involving 50 children (aged 1-18 years) with SSNS treated for over six months.
- Evaluations included ophthalmologic assessment, biochemical tests, and lumbar spine dual-energy X-ray absorptiometry (DEXA) for BMD.
- Statistical analysis correlated steroid dose and duration with bone and ocular outcomes.
Main Results:
- 50% of children had osteopenia, and 6% had osteoporosis.
- Longer steroid duration correlated with lower BMD (p=0.025).
- Ocular complications, mainly refractive errors (16%), were linked to longer steroid duration and higher cumulative dose.
Conclusions:
- Prolonged corticosteroid therapy in SSNS is associated with decreased BMD and ocular issues.
- Regular monitoring of BMD, vitamin D levels, and ophthalmologic status is recommended for long-term management.
Abstract:
Objective The main objective of this study is to assess bone mineral density (BMD) and ocular complications in children with steroid-sensitive nephrotic syndrome (SSNS) receiving prolonged corticosteroid therapy and to identify factors associated with these complications. Methods This cross-sectional observational study was conducted at a tertiary care center over 18 months. Children aged 1-18 years with SSNS who had received corticosteroids for more than six months were enrolled. Clinical details, including cumulative steroid dose and duration of therapy, were recorded. All participants underwent ophthalmologic evaluation, biochemical assessment, and lumbar spine dual-energy X-ray absorptiometry (DEXA) to determine BMD Z-scores. Associations between steroid exposure and bone and ocular outcomes were analyzed. Results Fifty children were included, 66% were boys, and the mean age was 6.08 ± 2.84 years. Osteopenia was found in 25 children (50%), and osteoporosis in nine (6%). Longer steroid duration was significantly associated with lower BMD (p = 0.025). Children with osteoporosis had significantly higher parathormone (PTH) and alkaline phosphatase (ALP) levels and lower vitamin D levels (p < 0.001). Ocular complications were identified in nine children (18%), most commonly refractive errors (16%). Refractive errors were significantly associated with longer steroid duration (p = 0.013) and higher cumulative steroid dose (p = 0.012). Posterior subcapsular cataract and raised intraocular pressure were observed in one child each. Conclusion Prolonged corticosteroid therapy in children with SSNS is associated with reduced BMD and ocular complications. Regular monitoring of bone health, vitamin D status, and ophthalmologic evaluation should be part of long-term care.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...